Zydus Lifesciences gets USFDA nod to mkt Scopolamine transdermal system
Scopolamine Transdermal System 1 mg/3 days had annual sales of USD 69.6 million in the US, the company said citing
Continue reading
Tag: USFDA
Aurobindo, others recall products in US market over production issue: USFDA
2 min read Last Updated : Aug 26 2024 | 7:57 PM IST Drug makers Aurobindo Pharma, Glenmark and
Continue reading
Sun Pharma receives US FDA approval for drug to treat alopecia areata
Sun Pharma stock was up 2.2 per cent in morning trade on BSE. 3 min read Last Updated : Jul
Continue reading
USFDA pulls up Sun Pharma for manufacturing issues at Dadra facility
3 min read Last Updated : Jul 04 2024 | 6:48 AM IST Sun Pharma failed to adequately clean
Continue reading
Indian firms fared better in USFDA inspections in recent years, says IPA
4 min read Last Updated : Jun 26 2024 | 11:14 PM IST Revised Schedule M implementation is going
Continue reading
Lupin, Eugia recall products from US over manufacturing issues: USFDA
Drugmaker Lupin and a unit of Aurobindo Pharma are recalling products from the American market due to manufacturing issues. 2
Continue reading
USFDA issues Form 483 with four observations to Dr Reddy’s API unit
The inspection was conducted from May 30, 2024 to June 7, 2024, it added. 1 min read Last Updated :
Continue reading
Aurobindo Pharma Q4 results: PAT rises 79.5% to Rs 908 cr, revenue up 14.8%
2 min read Last Updated : May 25 2024 | 9:51 PM IST Aurobindo Pharma, on Saturday, posted a
Continue reading
Cipla receives USFDA approval to market Lanreotide injection in US
Drug major Cipla on Wednesday said it has received approval from the US health regulator to market a generic medication.
Continue reading
Solara Active Pharma meets USFDA’s inspection at its Visakhapatnam facility
Solara Active Pharma Sciences Ltd has announced that the USFDA has completed the inspection at its multipurpose API manufacturing facility
Continue reading